Notice of Effectiveness · EFFECT
Iambic Therapeutics, Inc.
IAMNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-10-14
- Effective time (as filed)
- 16:00:00
- Form
- S-1
Registrant 1
- Registrant
- Iambic Therapeutics, Inc.
- Registrant CIK
- 0001997038
- File number
- 333-299057
Company context
We are a technology and clinical-stage life sciences company pursuing a fundamental shift in the biopharmaceutical industry. Our mission is to make better technology for better medicines. We do this by integrating leading proprietary, large-scale artificial intelligence (AI) with automated, scalable chemistry and biology experimentation. We call this approach molecular superintelligence.